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Abstract 
Aims and Objectives: This meta-ethnographic study identified behaviors associated with taking 
medications and medication adherence reported in qualitative studies of adults with chronic 
kidney disease (CKD) and co-existing multiple chronic conditions (MCCs).  
Background: To inform medication adherence interventions, information is needed to clarify the 
nature of the relationships between behaviors that support medication-taking and medication 
adherence in MCCs.  
Study Design: Meta-ethnographic review and synthesis 
Methods: CINAHL Complete, MEDLINE and PsycINFO databases were searched. Five 
qualitative studies met the inclusion criteria. A meta-ethnographic approach was used for 
synthesis. Medication-taking behaviors were abstracted from study findings and synthesized 
according to the contexts in which they occur and interpreted within new developing framework 
named the Medication-taking Across the Care Continuum with adherence-related Outcomes 
(MACO). 
Results: Twenty categories of medication-taking behaviors occurred in three main contexts: 1) 
patient-provider clinical encounters, 2) pharmacy encounters, and 3) day-to-day management. 
These behaviors are distinctly different, multi-level, and interrelated. Together they represent a 
process occurring across a continuum. 
Conclusions: Future medication adherence research should consider using a multi-level 
ecological view of medication management. Clinical practice and policy development can 
benefit from further understanding socio-contextual behaviors that occur across the continuum. 
Nurses should have greater presence in chronic disease management and be positioned to support 
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the day-to-day home management of patients’ medications.  
Relevance to Clinical Practice: Healthcare professionals can partner with patients to elucidate 
how these behaviors are enacted across the care continuum and in day-to-day management to 
identify opportunities to intervene on specific behaviors and promote medication adherence. 
Key words: medication management, medication adherence, comorbidity, chronic illness, 
behavior, compliance, self-management 
 




On the topic of medication management for Chronic Kidney Disease and 
Multiple Chronic conditions, this paper adds: 
 Medication management is a process that occurs across three interrelated 
contexts. 
 Healthcare team members should be aware that patients engage in 
complex medication-taking behaviors that span three interrelated 
contexts: clinical encounters, pharmacy encounters and day-to-day 
management.  
 Recommendations for research, clinical application and policy 
implications with respect to contexts are identified to improve medication 
adherence, calling nurses to the forefront in chronic disease management. 
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Chronic Kidney Disease (CKD) is progressive and irreversible (Pyram et al. 2012), can 
be managed with medications, but not cured, and affects people worldwide. An estimated 10% of 
the global population is affected by CKD (World Kidney Day 2016) and in adults over the age of 
65, approximately one quarter have CKD (NIDDK, n.d.; World Kidney Day, 2016; Zhang & 
Rothenbacher, 2008).  Left unmanaged or poorly managed, CKD can lead to kidney failure, 
known as end-stage renal disease (ESRD). The leading causes of ESRD are diabetes mellitus and 
hypertension (US Renal Data System 2011), which are physiologically interrelated chronic 
diseases.  
Self-management of CKD usually requires management of multiple chronic conditions. 
Slowing disease progression and managing underlying comorbidities are major goals of 
treatment in early CKD stages. Adherence to prescribed medications is critical to achieve goals 
of CKD management. In the early stages of CKD (Stages 1-3) treatment with an ACE inhibitor 
or angiotensin receptor blocker has been shown to reduce the risk for developing ESRD and slow 
disease progression, and use of statins reduces all-cause mortality by lowering the risk of 
myocardial infarction, stroke, and other cardiovascular events (Qaseem et al. 2013). In addition 
to these treatments, people with CKD and diabetes must also manage other prescribed 
medications to manage blood glucose levels and hypertension. Of those receiving treatment for 
ESRD, more than 80% are from well developed countries such as the US, Japan and China (Jha 
et al. 2013). For example, eighty-four percent of national health care spending in the US is for 
people who have one or more chronic diseases, and spending increases as the number of diseases 
multiplies (RWJ, 2010). Furthermore, for each Medicare patient who avoids dialysis progression, 
an estimated $250,000 can be saved (Diabetes Leadership Initiative 2012). In lower-income 
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countries, managing prevention of ESRD with multiple drug regimens is key to cost-effective 
care as dialysis and kidney transplant may not be readily available treatment options (White et al. 
2008).   
Background 
Medication adherence as defined by the World Health Organization (2003), as “the extent 
to which a person’s behavior [concerning] taking medication corresponds with agreed 
recommendations from a healthcare provider” (p. 17). Medication nonadherence widely varies 
but is estimated to occur in 17–74% (Karamanidou et al. 2008, Magacho et al. 2011) of people 
with CKD compared to 30-50% in other chronic diseases (Osterberg & Blaschke 2005, Schmitt 
et al. 2010, Shore et al. 2015). Many factors are associated with medication adherence including 
socio-economics, patient-provider relationships, healthcare conditions, medication treatment, and 
patient beliefs and capabilities (American Society on Aging and American Society of Consultant 
Pharmacists Foundation 2006, An & Nichol 2013). People managing CKD usually take from 5-
14 medications per day (Rifkin et al. 2010). Because of the complex interplay of these factors, 
there is a need to explore the specific behaviors involved in medication management. These 
behaviors are more than just taking or not taking prescribed medication; they include all 
behaviors that lead to taking or not taking prescribed medication.  
Understanding the full range of medication-taking behaviors from patients’ perspectives 
is needed for intervention development. Appropriate behavior change techniques can be 
integrated in interventions targeting important behavioral components that lead to medication 
adherence in CKD. Thus, the study purpose was to identify medication-taking behaviors reported 
in qualitative studies of patients managing CKD with multiple chronic conditions.  




A synthesis of the qualitative literature was undertaken using a meta-ethnographic 
approach (Britten et al. 2002b, Noblit & Hare 1988). This type of synthesis is interpretive in 
nature, seeking to transfer concepts and findings from one study to another which distinguishes 
this method from other types of qualitative syntheses and in particular distinguishes it from an 
integrative review (Britten et al. 2002b).  Our study was guided by the seven steps outlined by 
Noblit and Hare (1988) which include getting started; deciding what is relevant to the initial 
interest; reading the studies; determining how the studies are related; translating the studies into 
one another; synthesizing translations; and expressing the synthesis. Following the approach 
used by Britten and colleagues (Britten et al. 2002a), we chose to focus on concepts identified 
within study findings, rather than metaphors. Specifically, these concepts were identified 
medication-taking behaviors. 
Getting Started and Determining What is Relevant. We have combined Noblit and Hare’s 
(1988) first two steps in the section given the introduction of this paper provides the background 
that led to this synthesis and was the starting point for our review. The first step in the process 
was to clearly outline the objectives of our synthesis and develop search strategies, inclusion and 
exclusion criteria. The specific objectives were to 1.) identify medication-taking behaviors across 
studies that focused on CKD and multiple chronic conditions; and 2.) synthesize the behaviors 
across studies. We set our search strategies, inclusion and exclusion criteria based on achieving 
the stated objectives.  
Search Strategy & Sources 
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With the assistance of a university librarian, we systematically searched Academic 
Search Premier (EBSCO), CINAHL Complete, MEDLINE, PubMED and PsycINFO databases 
using search terms: “medication adherence or medication compliance” AND “qualitative 
research” AND “kidney” AND “chronic disease.” By including the key word “chronic disease” 
we were able to abstract studies of people with both CKD and multiple chronic conditions. We 
limited the search to scholarly (peer reviewed) journals published between 2004 and 2015.  
Inclusion and Exclusion Criteria 
To be included, studies had to be qualitative, conducted in adults who were 18 years of 
age or older diagnosed with CKD Stages 1-4 and co-existing multiple chronic conditions, and 
focused on medications.  Studies with people in CKD Stage 5 and undergoing dialysis were 
excluded. This search yielded 8 qualitative studies, 3 of which did not meet inclusion criteria 
(see Figure 1).  
Figure 1. PRISMA 














Reading the Studies. The third step in this synthesis focused on reading the studies to 
gain an understanding of the articles. We independently read and reread the articles to gain a 
deeper understanding of the medication-taking behaviors described within each article. In this 
process, we began to identify medication-taking behaviors within the text. We began 
highlighting these key behavioral concepts as we read to gain a deeper understanding of the 
behaviors described.  In this step we also independently assessed each article using Critical 
Appraisal Skills Programme (CASP) checklist questions for quality appraisal of qualitative 
research (CASP, 2014), following the adapted process used by Campbell et al. (2003). The 10-
item CASP Qualitative Research Checklist was completed independently by each author, for 
each of the five studies identified from the literature search. The first 9 questions on the checklist 
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required check-marking a response of “yes”, “no” or “unclear” for each of the quality criterion 
and the last question allowed for qualitative response about the value of the research.  Authors 
independently tracked comments about each assessment to inform discussions about the 
appropriateness of including the studies in the review.  
Determining How Studies Were Related. In this fourth step we began abstracting the key 
findings from each study in order to facilitate understanding of the findings across studies. We 
developed a table to track participants’ characteristics and identify key themes among the 
findings. Additionally, consistent with the purpose and objectives of our review, we abstracted 
all behaviors, line by line, related to the way people reported that they managed their 
medications. We defined medication management behaviors as “any self-described patient 
actions related to accessing, managing, or actual taking (e.g., swallowing) of medication.” In 
articles that included qualitative data from healthcare providers or system-related factors that 
may affect medication-taking behaviors, only behaviors described by patients were abstracted.  
Translating studies into one another. First, we organized studies by date of publication to gain a 
historical understanding of the findings. We then reviewed the first study, participating in a 
constant comparison and “reciprocal translation” with the findings of the second study (Britten et 
al. 2002b, Pound et al. 2005).  To accomplish reciprocal translation, we began with the list of 
behaviors abstracted from the first study and then added the behaviors abstracted from the 
second study, looking for similarities and differences. Adding the third paper to the review, we 
compared behaviorally focused findings to abstract and synthesize similarities and differences 
across studies (Britten et al. 2002b). This process was followed until all studies had been 
reviewed and findings compared with each other. We then synthesized these findings into a table 
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to allow us to examine which studies included the abstracted behaviors and used this to 
summarize our findings.  
Synthesizing Translations. To synthesize the findings, we discussed the behaviors and the 
contexts in which they were reported to occur. This discussion included interpreting how the 
behaviors were related to one another and supported medication management. As we discussed 
the interrelationships, we began referring to a developing framework named the Medication-
taking Across the Care Continuum and Adherence-related Outcomes (MACO) framework 
(Authors initials XXX) to describe the processes that lead to medication taking, the contexts in 
which they occur across the care continuum, and the medication adherence related outcomes 
specific to controlling disease with prescribed medications. 
Expressing the Synthesis. The final step in the seven-step process of conducting a meta-
ethnographic synthesis is discussing the implications of the findings. In our discussion section of 
this article, we discuss the implications of our findings for research and clinical application and 
consider policy implications. 
Results 
Study Characteristics 
Five studies meeting study inclusion criteria were reviewed and appraised for quality 
(Table 1). Four publications included at least one of the same authors. Interrater agreement on 
study quality was adequate, with 100% agreement across all CASP criteria except one item on 
the checklist pertaining to whether the authors of the studies addressed how the relationships 
between the researcher and participants had been considered. In particular, two different articles 
reviewed were marked by one of us as unclear for this quality criterion. We discussed and 
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resolved the concern and included the article. Thus, our review included the five studies 
abstracted from the literature search.  
Studies represented a diverse population of 108 patients from Australia, England, and the United 
States. Two studies involved the same group of patients (Williams et al. 2008, Williams et al. 
2009). On average, patients were 60 years old (range 21-90 years) and taking an average of 8 
medications. Patients across studies took 1-14 medications per day. In addition to CKD, diabetes 
and hypertension, other co-morbid chronic conditions included hyperlipidemia, bone disease, 
and depression.  
Synthesis 
Noblit and Hare (1988) describe the process of translating studies into one another 
involves comparing key metaphors or concepts with one another. Given our focus was on 
identifying behaviors among study findings, the central concepts identified across studies were 
the medication management behaviors. To gain an understanding of how the different behaviors 
were reported across studies, we developed a table with the behaviors in the left column and then 
marked an “X” for each study that reported that particular behavior (See Table 2). The result was 
20 different categories of medication-taking behaviors that occurred in the three contexts in the 
MACO framework. We maintained the central concepts, in the case of our synthesis, the central 
behaviors, abstracted from each of the studies. These central behaviors, twenty in all, are 
identified in a table showing which studies they were abstracted from. The MACO framework 
served to help organize the behaviors within the contexts in which they occur, which include 
clinical encounters, pharmacy encounters and day-to-day management. The framework was not 
applied a priori to the synthesis, rather it emerged in our discussions about how the identified 
behavioral categories (i.e. the key concepts), from our review were related to one another.  
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Following the Noblit and Hare approach (1988), making comparisons across studies 
helps to uncover hidden meanings. In the case of our discussions, it was apparent that the central 
behaviors we identified across studies also occurred across a continuum of care.  
Based on our review, central behaviors patients engage in include: (1) communicate with 
providers, (2) seek information, (3) keep current medication lists, (4) appraisal, (5) use personal 
or family past experience to make decisions, (6) make risk assessments, (7) denial as coping 
mechanism, (8) access resources, (9) get prescriptions filled, (10) manage side effects, (11) 
create or establish routines, (12) prioritize medications, (13) prepare correct doses of 
medications, (14) prepare and administer doses, (15) self-monitor, (16) use prompts as 
reminders, (17) respond to forgotten medications, (18) trial-and-error, (19) keep equipment 
needed to titrate doses in good working order, and (20) maintain prescriptions on hand. In 
synthesizing the literature, we have considered how these behaviors are related to one another 
and when they occur. The new meaning added by this synthesis is in understanding that these 
behaviors occur across a continuum of care and in different yet interrelated contexts (clinical 
encounters, pharmacy encounters and day-to-day management), which ultimately influences 
whether patients adhere to prescribed medications. These behaviors therefore are interrelated, but 
occur across the three contexts of the clinical encounter, pharmacy encounters and day-to-day 
home management. 
Medication-taking behaviors were carried out in patients' daily lives and involved 
interactions with family members, healthcare providers, and the healthcare system. The most 
frequently mentioned behaviors occurred across three contexts including 1) communicating with 
providers during clinical encounters, 2) getting prescriptions filled/refilled at the pharmacy, and 
3) day-to-day home management of medications, with emphasis on managing side effects and 
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prioritizing medication taking. We used the contexts from the MACO framework to organize the 
categories of behaviors across the continuum of care and used these contexts to further elaborate 
on the behaviors and relationships in the descriptions below. 
Patient-Provider Encounters 
Patients across the five reviewed studies described the importance of the patient-provider 
relationship. Communicating with Providers was identified as important to support open 
discussion about medications with healthcare providers (Williams, 2008) including consultants, 
nurses, and physicians (Walker et al. 2012). This encounter can occur in a hospital or provider 
clinic office setting or any setting in which there is a communication between a patient and a 
provider who has responsibilities for prescribing. Information shared during clinical encounters 
provides patients with information that may inform their primary decision about whether to take 
medications. These decisions may be based on beliefs about the medications, costs of 
medications, as well as patient values and preferences. The decisions are also based on how well 
this information is communicated to the patient in a way the patient clearly understands. For 
example, during clinical encounters, providers often set target physiological measures for disease 
control (e.g. blood pressure) influenced by medication taking. These physiological measures are 
the therapeutic targets of medications, and therefore not taking medications as prescribed or not 
taking them at all may lead to poor outcomes relative to disease control. Patients in one study 
considered these targets difficult and unrealistic to achieve (Williams & Manias 2013).  
Patient behaviors associated with patient-provider communication included managing 
conflicting advice from providers (Walker et al. 2012), withholding information from physicians 
to avoid new prescriptions (Williams & Manias 2013), and questioning why they were taking 
certain medications (Walker et al. 2012). Distrust of providers was a concern and patients spent a 
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great deal of time searching for satisfactory health care resulting in frequent provider changes 
(Senteio & Veinot 2014). 
Because patients across studies were managing multiple chronic conditions, it required 
them to manage several medications used to treat different conditions. This required patients to 
keep and maintain a comprehensive current list of medications (Williams et al. 2008). 
Communicating this list to providers was identified as a medication-taking behavior requiring 
skills in navigating the health system (Williams & Manias 2013) and communicating with 
healthcare providers. These factors likely then influenced pharmacy encounters. 
Pharmacy Encounters 
Acquiring medications required patients engage in behaviors associated with pharmacy 
encounters, the second context. Pharmacy encounters involve several patient behaviors, which 
we have categorized as a) appraisal, b) accessing resources, and c) getting prescriptions filled.  
The decision to fill a prescription involves appraisal, that is, patients questioning the need 
for different medications (Walker et al. 2012) and making risk assessments regarding, for 
example, the long- term implications of medications (Williams et al. 2009) and the cumulative 
effect of their diseases (Williams et al. 2009). This requires patients to accept responsibility for 
their actions related to the disease and medications (Williams et al. 2009). Another behavior 
related to appraisal identified was that of denial, which was used as a coping mechanism. Some 
patients denied the fact that they needed medication for chronic disease management. 
Appraisal, accessing resources and getting prescriptions filled leads to decision making 
about whether to take medications. Appraisal can be influenced by outside information the 
patient has received since the clinical encounter, including that from friends and family, the 
Internet, and other sources such as the media (Walker et al. 2012) (TV commercials, social 
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media, informational pamphlets)(Senteio & Veinot 2014, Williams & Manias 2013, Williams et 
al. 2008). Patients using information from family members (Walker et al. 2012) or other outside 
sources to inform medication taking were behaviors we categorized as information seeking. 
Diabetes and hypertension tended to be familial, and therefore knowledge came from family 
experience. Patients also learned from prior experiences in which medications had helped them 
feel better when they experienced symptoms or, in some cases, when medications had helped 
keep them alive (Williams & Manias 2013). Past healthcare experiences provided background 
knowledge and contributed to certain beliefs about their care (Senteio & Veinot 2014). When 
they did not understand information (Williams et al. 2008) patients sought explanations from 
reference books, the Internet, and doctors (Williams & Manias 2013). This information then 
helped patients make decisions about medication taking (Williams & Manias 2013). Behaviors 
related to information seeking included reading medication-related materials (Williams et al. 
2008) and information on the Internet, as well as seeking verbal advice from practitioners 
(Williams & Manias 2013). 
In addition to appraisal, patients spent time engaging in behaviors to secure medications 
that we categorized as accessing resources. Accessing resources encompasses behaviors that 
lead to obtaining actual medications such as ordering the medication, securing transportation 
(Walker et al. 2012),(Williams et al. 2008), and having the ability to pay for medications 
(Williams et al. 2008). Senteio and colleagues (2014) asserted that in order to secure 
medications, patients had to respond to changes in insurance coverage and medical care. Medical 
care was noted in another study when patients needed to follow up with an additional physician 
appointment when a prescription had run out (Williams et al. 2008). 
Getting prescriptions filled or refilled was mentioned in four studies (Senteio & Veinot 
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2014, Walker et al. 2012, Williams & Manias 2013, Williams et al. 2008) and required planning 
and time management skills (Williams et al. 2008). It required patients to order medications 
when needed (Walker et al. 2012), and this was more difficult when they had to deal with refills 
for medications at different times (Williams et al. 2008). When medications were not in stock at 
pharmacies, patients resorted to other options such as using other family members’ medications 
(Senteio & Veinot 2014).  
Day-to-Day Home Management  
Managing side effects. Management of side effects was discussed in four studies (Walker 
et al. 2012, Williams & Manias 2013, Williams et al. 2008, Williams et al. 2009). Effective 
management of side effects required knowledge of side effects and relating symptoms and side 
effects to medication (Williams et al. 2008). Medication-taking behaviors used to manage side 
effects included altering doses of medications, adjusting timing of the regimen, or deliberately 
missing medications (Walker et al. 2012).  Patients were able to anticipate side effects (Williams 
et al. 2008), and in some cases patients recognized that they could avoid side effects if they 
stopped taking medications (Williams & Manias 2013, Williams et al. 2009). When side effects 
occurred, communication with the pharmacy and physician about current medication was an 
additional behavior associated with managing side effects (Williams et al. 2008). 
Prioritizing Medications. Prioritization efforts were associated with decision-making 
about which medications to take while prioritizing competing demands associated with family 
obligations. Prioritization of medication included deciding which medicines were important 
(Williams et al. 2008) and deciding which ones to take or not take (Williams et al. 2008), which 
included prioritizing medical directives (Senteio & Veinot 2014). Patients independently decided 
which chronic conditions were more important and chose medications to take based upon this 
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assessment (Williams et al. 2009). They prioritized information that helped inform medication 
taking (Williams et al. 2009). They also took medications for conditions deemed to be more 
salient (Williams et al. 2009), and in some cases this meant choosing medications they thought 
to be absolutely necessary for health (Williams & Manias 2013). Some patients also prioritized 
medications based on cost (Senteio & Veinot 2014). Finally, prioritization included managing 
competing external demands that complicated medication taking (Williams et al. 2009). Patients 
often prioritized family needs ahead of taking medications (Williams et al. 2009). Effective 
medication taking required interrupting family activities if necessary to take medications as 
scheduled (Williams et al. 2009), as well as managing distractions and competing demands that 
complicated medication taking (Senteio & Veinot 2014, Williams & Manias 2013, Williams et 
al. 2009). 
Preparing correct doses of medications. Preparing medications for medication 
administration was an important behavior. This included recognizing specific medication 
characteristics such as the color, size, and brand name differences in order to take the right 
medication at the right time (Williams et al. 2008). Sorting medications was important in 
preparing correct medications, and family members often supported this function (Walker et al. 
2012). In order for patients to prepare and administer medication doses, they needed to have a 
clear head (Williams et al. 2008). One patient stated that a simple task such as cutting a pill in 
half was challenging due to age. They also needed to be able to swallow multiple pills, difficult 
for some (Williams et al. 2008). In some cases, patients required assistance with medication 
taking from friends, spouses, or other family members (Williams & Manias 2013). In other 
circumstances, such as blood glucose monitoring, patients had to keep their equipment in good 
working order to determine the medication dose needed. Maintaining properly working 
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equipment was mentioned in only one study (Williams & Manias 2013). In this population, the 
equipment might include glucose monitoring equipment or blood pressure monitors.  Since some 
medication-taking behaviors involve self-monitoring, maintaining the equipment is important.  
Self-monitoring and Independent Behaviors. Patients participated with varying degrees in 
their medication-related self-management. For example, Williams et al. (2009) reported that 43% 
of the patients interviewed did not know the results of their blood pressure readings and believed 
this knowledge was relevant to the physician, not necessarily to themselves, whereas some 
patients in Walker’s study (Walker et al. 2012) checked their own blood pressures and 
maintained copies of relevant lab tests. Some patients reported that they believed nothing 
unexpected would happen if they kept an eye on the disease process (Walker et al. 2012). 
Creating or establishing routines. Patients described establishing routines by aligning 
medication taking with daily routines such as mealtimes (Walker et al. 2012). This required 
diligence (Senteio & Veinot 2014), but patients also noted a “cyclical struggle,” being diligent 
intermixed with periods of “laxity.” Adjustments to eating schedules and sleeping later than 
normal disrupted medication-taking routines. When new medications were prescribed, patients 
had to disrupt their established routines and develop new ones (Williams et al. 2008).   
Using prompts as reminders. Patients also reported the use of various prompts to help 
them remember to take medications, including pillboxes, calendars (Williams & Manias 2013, 
Williams et al. 2008), charts, diaries (Walker et al. 2012), and automatic reminders on a mobile 
phone (Williams & Manias 2013). These behaviors targeted remembering to take medications. 
Patients also used prompts to help them remember if they had taken their medications (Williams 
et al. 2008). For example, they counted used needles at the end of each day to be sure all insulin 
had been taken (Williams et al. 2008). No elaboration was provided about what they did when 
MEDICATION-TAKING BEHAVIORS IN CKD	
	 19
there was a discrepancy.  
Responding to forgotten Medications. Remembering to take medication is a critical 
component of medication taking. Patients often forgot to take their medications, but when they 
remembered to take them, the medication may not have been available because they were outside 
their normal routines. Keeping duplicate supplies in other convenient locations was an additional 
behavior used (Williams, 2008). 
 In addition to the above-mentioned behaviors, patients also reported using trial-and-error 
medication-taking behaviors to manage symptoms and side effects of medications. In two studies 
(Williams & Manias 2013, Williams et al. 2008), patients described manipulating medications to 
achieve desired outcomes, meaning they added new medications such as supplements and 
complementary alternative medications (e.g. fish oils, vitamin D) (Williams & Manias 2013) or 
stopped taking medications to determine the effects of this on their symptoms. In some cases, 
patients would make these adjustments without their doctors’ knowledge or advice; patients 
reported they would stop medications and monitor if symptoms disappeared before seeking 
medication advice (Williams et al. 2008). In some cases patients would adjust the timing of 
medication administration or avoid taking medications at all (Williams et al. 2008). Decision-
making was a large component of these “trial-and-error” behaviors. Physical symptoms or lack 
thereof informed patients’ decisions about medication effectiveness (Williams & Manias 2013). 
In some cases, people would engage in other self-management behaviors such as diet to avoid 
taking medications (Williams et al. 2009). Trial-and-error methods may be one way that people 
try to avoid changes in their lifestyle perceived as negatively affecting their quality of life 
(Williams et al. 2009).  
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Persistent medication taking involves getting medications refilled when they run out, 
which may require new prescriptions with the goal being to keep medications on hand (Senteio 
& Veinot 2014, Williams & Manias 2013, Williams et al. 2008). Previously identified behaviors 
contribute to refilling prescriptions, as well as patients’ recent experiences taking their 
medications. These experiences are based on patient preferences and values. For example, if 
medications interfere with an activity that is important to them they may not want to refill the 
prescription. These decisions represent another decision time point that affects long-term 
medication taking and management behaviors and whether patients follow through with getting 
the prescription refilled. When patients had multiple different medications and refills occurred at 
different times, it was inconvenient to go back and forth to the pharmacy so often, and therefore 
patients often stretched their medications until the next time they needed to go to the pharmacy 
(Senteio & Veinot 2014). Additionally, prescriptions were often time limited or had expired, 
requiring patients to schedule and attend a physician appointment to obtain a new prescription 
(Williams & Manias 2013). Sometimes the unavailability of medications from the pharmacy and 
insurance interfered with patients being able to obtain their medications in a timely manner. 
Patients also mentioned that sometimes pharmacies did not have medications in stock (Williams 
et al. 2008). When multiple medications were prescribed, patients had to create systems to 
reorder and secure multiple prescribed medications (Walker et al. 2012). In some cases when 
patients ran out of medications, days or weeks would go by without them taking medications 
(Williams et al. 2008). To stretch medications, patients would skip them for days or weeks to 
make them last until the next prescriptions were available (Senteio & Veinot 2014). This 
required patients to keep track of medications and refill dates (Williams & Manias 2013) in order 
to maintain a supply of medication (Williams & Manias 2013). 
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To further illustrate the translation of findings and synthesize the results, we developed 
Figure 2. [insert Figure 2 here]  
 
We organized the 20 categories of behaviors in the contexts in which they occurred. 
Behaviors that occur in patient-provider encounters affect behaviors that occur subsequently in 
pharmacy encounters and the day-to-day management of medications. Likewise, day-to-day 
home management behaviors affect subsequent behaviors of refilling prescriptions and clinical 
encounters. This reflects that medication management is cyclical and occurs across a continuum. 
Discussion 
In this review, we identified medication-taking behaviors used by people with CKD and 
multiple chronic conditions. These behaviors occur within three interrelated contexts to include 
patient-provider encounters, pharmacy encounters and the day-to-day home management of 
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medications. These contexts represent managing medications across a continuum, with specific 
behaviors occurring across each context, with the exception of information seeking which was a 
behavior noted in all three contexts. While we identified and described 20 categories of 
medication-taking behaviors embedded in these contexts, the most important finding from this 
synthesis is that, these behaviors are distinctly different yet interrelated and represent medication 
management as a process that occurs across a continuum.  
Contexts in which different medication management behaviors occur are relevant to 
developing theoretical models. Commonly studied behavior change theories target individuals, 
but none reflect the socio-contextual behaviors that occur across the continuum, reflecting a 
multi-level ecological view of medication management. Although there is recognition that 
medication adherence is a multi-level problem, no interventions have approached medication 
adherence guided by ecological theories. In particular, a recent meta-analysis reported that most 
theory driven interventions are focused on cognitive factors such as knowledge, beliefs, and 
attitudes (Conn et al. 2016) that have had limited effect on medication adherence.  
Adopting a multi-level ecological view of medication management requires research 
methods to better understand these behaviors in context. First we need to continue to empirically 
explore medication adherence across the three contexts. Several systematic reviews and meta-
analyses have demonstrated limited effectiveness of interventions to improve medication 
adherence and improve clinical outcomes (Conn et al. 2015, Fletcher et al. 2015, Viswanathan et 
al. 2015). While the measurement of medication adherence is often implicated when interpreting 
findings (Thakkar et al. 2016, Vik et al. 2004, Voils et al. 2011), little attention has been paid to 
the interrelated contexts in which the interventions are delivered. Second, longitudinal research 
may help understand the cyclical nature of these behaviors across contexts and the continuum 
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that leads to long-term medication management. Future research that includes longitudinal 
designs with measures of specific medication-taking behaviors in people with CKD and multiple 
chronic conditions is recommended.  
Clinical Application 
Healthcare patient-provider interactions require effective communication behaviors so 
patients can partner with healthcare team members. Patients in one study (Senteio & Veinot 
2014) reported physician communication as problematic and poor physician communication is 
linked with an almost 20% higher risk of medication nonadherence. Our review also highlighted 
patients deliberately chose to not communicate certain information such as their symptoms, side 
effects, or changes they had made in their medication regimen because they feared receiving new 
medication prescriptions which was viewed as disruptive in daily living. This patient population 
is particularly vulnerable to progressively worsening kidney disease, cardiac events and mortality 
and withholding information to prevent disruptions in daily living may ultimately lead to poorer 
outcomes. These findings call attention to the need for providers to seek to understand patients’ 
day-to-day management of medications. Repeated dialogue with patients that includes education 
with behavior support can help bridge the gap between clinical encounters and daily experiences 
of managing multiple medications for multiple chronic conditions. Interventions that include 
education with behavior support provided with patient contact over a period of weeks or months 
have been found to be the most effective across multiple clinical conditions (Viswanathan et al. 
2012).  
Policy Implications 
Adjustment of medication dosing was a medication-taking behavior mostly associated 
with patients desire to self-manage their conditions. In some cases it was difficult for patients to 
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prepare and administer their own medications, in other cases patients did not have access to 
needed medications. From a policy perspective, in order to support medication management, 
patients need access to medications. This includes ensuring medications are cost effective, 
available in sufficient quantities and drug development pays particular attention to patient 
reported outcomes. International efforts to address system level barriers such as the Australian 
National Medicines Policy are targeting increased access to medications including controlling 
costs, appropriateness of prescribing and working with pharmaceutical industry to support 
development of medicines to increase availability (2014). These efforts mainly affect the clinical 
and pharmacy encounter contexts and help improve access to needed medications. Policy efforts 
should also consider once access to needed medications is improved, how people can best be 
supported in their day-to-day medication management. Consideration should be given to nurses 
to help support patients in their day-to-day medication management as their autonomous scope 
of practice includes enhancing patients’ functional capabilities and symptom management. 
Nurses may be able to help bridge care across the continuum; however the economics of this 
endeavor need further exploration.  
Methodological Strengths and Limitations 
This synthesis contributes a greater understanding of the complex behaviors associated 
with medication adherence. Meta-ethnography permits findings from multiple studies to be 
combined, leading to new interpretations of the combined data (Britten et al. 2002b) . In this 
way, the data abstracted from published reports becomes primary data and allows for greater 
insight across a body of literature. The literature included in this study was limited to five 
studies, therefore as new literature is identified, the synthesized findings herein should be either 
confirmed or refuted, which is a strength of the meta-ethnographic approach in synthesizing 
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literature. Our synthesis described a continuum of behaviors across three contexts; however the 
studies in this review were cross-sectional; further study is needed to empirically confirm which 
behaviors may occur at different time points, such as which behaviors are specific to patient-
provider encounters, patient-pharmacy encounters, or patient day-to-day management, and how 
they may change over time. Reported findings also include both patient reported findings and 
authors’ interpretations and therefore require further validation. Intervention design should 
consider the range of these medication-taking behaviors, the different skills needed at these 
different time points, which behaviors lead to positive or negative outcomes, and which should 
be targeted during intervention delivery.  
Conclusion 
There are multiple categories of distinctly different medication-taking behaviors that 
occur across a continuum of interrelated contexts. The majority of patient behaviors identified 
occur within the day-to-day context; however these behaviors are affected by the behaviors and 
contexts that precede day-to-day management. A multi-level ecological view of medication 
management should guide medication adherence research. An ecological understanding of 
medication management that includes the socio-contextual behaviors that occur across the 
continuum can be applied to clinical practice and policy development.  
Relevance to Clinical Practice 
This synthesis calls attention to the complexity of medication management that occurs 
across different contexts, yet demonstrates the interrelationships of contexts and subsequent 
decision-making and management of medications. The health care team, including nurses, 
physicians and pharmacists, has the opportunity to support patients with many of these 
medication-taking behaviors. In developing better relationships with patients, healthcare 
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providers should elucidate patients’ experiences with managing their medications and help 
devise interventions that will support adherence and address patients’ concerns about taking 
medications. Nurses are positioned to support patients’ medication management by helping to 
identify barriers to enacting medication-taking behaviors. 
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Table 1. Study Characteristics 
1st  Author 
/ Year 
Country Purpose  Design Sample / Data Collection 
Williams 
2008 
Australia Examine factors that affect 
medication adherence when 







23 patients with CKD and DM 
Mean age = 59.3 (SD = 15.5) 
65% male 
Number of prescribed medications: median = 10 
(range 4-14) 
Patients had a median of 5.5 additional chronic 
conditions including hyperlipidemia, bone 




Australia Examine irrational thought as a 





23 patients with CKD and DM 
Mean Age = 59.3; SD = 15.5 
65% male 
Individual interviews 
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1st  Author 
/ Year 
Country Purpose  Design Sample / Data Collection 
Walker 
2012 
England Explore the experience of 
integrating lifestyle changes into 
daily living when progressing to 
CKD Stage 4. 
Exploratory-
descriptive 
9 patients with CKD 
GFR < 25 mL/min (MDRD) 





Australia Explore the motivation and 
confidence to take medications as 
prescribed during an intervention 
trial. 
 
Secondary analysis of 
interview data from a 
randomized controlled 
trial 
39 patients with CKD, DM, and HTN 
GFR > 15 ≤ 60 (MDRD) 
Mean age = 68 (SD = 8.3) 
56% male 
Number of prescribed medications: Mean = 7.6 
(SD = 2.6; range 1-10) 






challenges of African Americans 
Grounded theory 37 patients with at least two of the following 
conditions: CKD, DM, or HTN 
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1st  Author 
/ Year 
Country Purpose  Design Sample / Data Collection 
living in high-poverty 
neighborhoods with more than 
one chronic condition. 












& Walker, 2009) 




(Senteio & Veinot, 
2014) 
Patient-Provider Clinical Encounters 
Communicate with providers X  X X X 
Seek information*  X   X X 
Keep current medication list  X   X  
Pharmacy Encounters 
Appraisal   X   







& Walker, 2009) 




(Senteio & Veinot, 
2014) 
Use personal or family past 
experience to make decisions    X X X 
Make risk assessments  X   
Denial as coping mechanism   X    
Access resources X  X  X 
Get prescriptions filled X  X X X 
 
 
Day-to-Day Home Management 
Manage side effects X X X X 
Create or establish routines  X X  X 
Prioritize medications X X  X X 
Prepare correct doses of 
medications  X  X   
Prepare and administer doses X   X X 
Self-monitor   X X   
Use prompts as reminders  X X X 
Respond to forgotten medications X     







& Walker, 2009) 




(Senteio & Veinot, 
2014) 
Trial-and-Error  X X  X 
Keep equipment needed to titrate 
doses in good working order.    X  
Maintain prescriptions on hand X   X X 
*occurs across contexts      
	
 
